University of Melbourne-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2024

  1. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

    Stroke, Vol. 55, Núm. 2, pp. 392-402

2023

  1. Regular Medications in the Emergency Department Short Stay Unit (ReMedIES): Can Prescribing be Improved Without Increasing Resources?

    Hospital Pharmacy

2022

  1. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial

    The Lancet, Vol. 400, Núm. 10357, pp. 997-1007

2019

  1. Dabigatran for prevention of stroke after embolic stroke of undetermined source

    New England Journal of Medicine, Vol. 380, Núm. 20, pp. 1906-1917